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Abstract
Gastric cancer is the second most frequent type of neoplasia and also
the second most important cause of death in the world. Virtually all the
established cell lines of gastric neoplasia were developed in Asian
countries, and western countries have contributed very little to this
area. In the present study we describe the establishment of the cell line
ACP01 and characterize it cytogenetically by means of in vitro immor-
talization. Cells were transformed from an intestinal-type gastric
adenocarcinoma (T4N2M0) originating from a 48-year-old male pa-
tient. This is the first gastric adenocarcinoma cell line established in
Brazil. The most powerful application of the cell line ACP01 is in the
assessment of cytotoxicity. Solid tumor cell lines from different
origins have been treated with several conventional and investiga-
tional anticancer drugs. The ACP01 cell line is triploid, grows as a
single, non-organized layer, similar to fibroblasts, with focus forma-
tion, heterogeneous division, and a cell cycle of approximately 40 h.
Chromosome 8 trisomy, present in 60% of the cells, was the most
frequent cytogenetic alteration. These data lead us to propose a
multifactorial triggering of gastric cancer which evolves over multiple
stages involving progressive genetic changes and clonal expansion.
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Introduction
Gastric carcinoma is the second most
common type of malignancy and also the
second most common cause of mortality in
the world (1,2). In 1999 stomach cancer was
responsible for the largest number of deaths
caused by neoplasms in Brazil. The State of
Pará has a high incidence of this type of
neoplasia. The gastric cancer presents the
biggest proportional distribution of the total
of deaths for cancer in men in the State of
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Pará (25.9%) (3). Its capital, Belém, is 11th
in the number of cases of gastric cancer per
inhabitant among all cities of the world with
data available on cancer incidence (1).
There are few published cytogenetic stud-
ies of gastric carcinoma, with only 128 cases
reported to date (4,5). Virtually all of the
established cell lines were developed in Asian
countries, with western countries having con-
tributed relatively little to this area. The
ACP01 cell line described here is the first
line of adenocarcinoma cells developed in
Brazil. Cytogenetic studies of gastric neo-
plasia conducted in western nations are rare,
mainly due to technical difficulties related to
in vitro cell culture (6). Nevertheless, vari-
ous chromosome alterations have been re-
ported in gastric cancer, involving different
chromosomes, such as chromosomes 3, 5, 6,
8, 12, 13, and 17 (7-9).
Gastric cancer cell lines have been used
as a biological model to obtain information
about the clonal evolution of this malig-
nancy (6,10,11). Yet, in spite of the impor-
tance of gastric cancer, relatively few such
cell lines are available (12). So far, 59 lines
have been cultured, 14 of which were from
primary tumors (13-23) and the remainder
from secondary tumors or metastases (10,12,
14-17). Most of these cell lines (78%) were
isolated in Asia (6).
Clearly, it is necessary to produce more
gastric cancer cell lines to allow the study of
the phenotypic diversity of stomach neo-
plasms and to develop models which are
adequate for the study of such tumors
(11,16,18). We developed and characterized
cytogenetically a cell line called ACP01 from
a gastric adenocarcinoma removed from a
patient who lived in the State of Pará, Brazil.
Material and Methods
Sample
Patient A.M.B., a 48-year-old male of
mixed European and African descent, was
submitted to subtotal gastrectomy followed
by lymphadenectomy, and the material re-
moved from the antrum was analyzed. The
patient had not been treated with radiation or
chemotherapy. He was previously informed
about this study and gave the written in-
formed consent. The study was approved by
the Ethics Committee of the Hospital Uni-
versitário João de Barros Barreto. The tumor
material was used for histopathological study,
for tissue culture and for cytogenetic analy-
sis.
Histopathology
The material was fixed in 10% formalde-
hyde, embedded in paraffin, sectioned, and
stained with hematoxylin-eosin.
Tissue culture, in vitro immortalization,
and morphological cell analysis. Fragments
of the surgical specimens, received under
sterile conditions, were cut into very small
pieces, treated with 0.1% collagenase IV
(Sigma, St. Louis, MO, USA) and added to
sterile bottles containing HAM-F10 medium
(Sigma) supplemented with 20% fetal calf
serum and antibiotics. Cells were grown at
37ºC. The culture was immortalized in vitro
by spontaneous transformation. The mor-
phological analyses of the cell line, which
we named ACP01, were carried out using
microphotographs of cultures prepared daily,
taken with an inverted Axiovert 25 micro-
scope (Zeiss, Jena, Germany), and mitotic
activity was determined.
The mitotic index (MI) was calculated
using the formula: MI = m/N x 100, where
m = number of cells in mitosis; N = number
of cells in interphase and number of cells in
mitosis; 100 = percentage factor.
Cryopreservation
The ACP01 cell line was cryopreserved
according to the “previous dehydration” pro-
tocol developed in our laboratory. This pro-
tocol provided maximum viability of this
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cell line as determined by Trypan blue anal-
ysis. The protocol consists of the following
steps: I. Dehydration - The cells are removed
in a trypsin-EDTA solution and placed in a
dehydrating solution (1.2 M sucrose, 20%
fetal calf serum, and 20% Hanks’ solution)
for 20 min. II. Freezing - The cells are placed
in a cryoprotective solution maintained at
10ºC (0.5 M sucrose, 33% HAM F-10 medi-
um, 30% fetal calf serum, and 7% glycerol),
and the temperature is then gradually re-
duced to -8ºC for 4 h, -20ºC for 6 h, and to
-60ºC in liquid nitrogen (N2) for 1 h, and the
cells are then immersed in liquid N2. III.
Thawing - This is done abruptly, subjecting
the cells to a drastic temperature change
(-96º to 37ºC), after which they are placed in
a rehydrating solution (0.3 M sucrose, 30%
fetal calf serum, and 25% Hanks’ solution).
After this procedure, the material is washed
once or twice and then transferred to tissue
culture bottles, where it is incubated and
maintained at 37ºC.
Cytogenetics
For cytogenetic analysis, three different
passages of the cell line, that was in an
exponential growth phase, were synchro-
nized (19) and blocked with 0.0016% colchi-
cine, harvested with 0.05% trypsin, treated
with hypotonic solution (0.075 KCl) for about
20 min at 37ºC, and fixed with 3:1 methanol/
acetic acid. Slides were submitted to stan-
dard Giemsa staining and trypsin-Giemsa
banding (GTG-banding). The description of
chromosome aberrations was based on the
recommendations of the International Sys-
tem for Human Cytogenetic Nomenclature
(ISCN 1995) (20).
Results
Establishing the permanent culture
We cultured 22 primary gastric adeno-
carcinomas, only one of which was immor-
talized in vitro by spontaneous transforma-
tion, a biological phenomenon that enabled
us to produce the ACP01 cell line.
Histopathology
The gastric lesion was classified as an
intestinal-type gastric adenocarcinoma (21).
According to the UICC (Union Internationale
Contre Le Cancer) standardization (22), this
stage was classified as T4N2M0.
Morphological analysis
The passages grew in an unorganized
single layer, with some agglomerations (Fig-
ure 1), heterogeneous divisions (bipolar and
multipolar) (Figure 2A-C), and a cell cycle
approximately 40 h long, with maximum
confluence at 74 h.
Figure 1. Formation of agglom-
erates in the culture of the
ACP01 cell line, indicating a loss
of contact or density inhibition.
These cells had undergone the
12th passage (Magnification:
40X).
A B
C
Figure 2. Heterogeneity of the
cell division of ACP01. A, Bipo-
lar cell division. B, Tripolar cell
division. C, Multipolar cell divi-
sion (Magnification: 100X).
40 µm
100 µm
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Phase of the ACP01 cell line
The ACP01 cell line is presently in its
63rd passage; the first stored sample was
prepared at the sixth passage. We now have
a stock of cells maintained in liquid nitrogen
that is available to whoever is interested in
working with this line.
Cytogenetic analysis
Chromosome analyses were carried out
on three different passages (6th, 12th, and
35th).
Distribution of chromosome numbers.
Analysis of the modal number revealed that
the ploidy of the ACP01 cell line evolved
from diploid, at the 6th passage, to triploid,
at the 12th and 35th passages, with consider-
ably fewer diploid cells at the 35th than at
the 12th passage. Each of the three passages
analyzed presented chromosomal variation.
This variation is shown in Table 1.
Karyotypes. Of the three passages ana-
lyzed (6th, 12th and 35th), only the 6th was
diploid, which made it impossible to exam-
ine changes in chromosome numbers in the
other two passages (20). Twenty metaphases
of each passage were analyzed by GTG-
banding. The composite karyotypes of each
passage are shown in Table 2. No normal
cells (46,XY) were found in our analysis. As
a control we used healthy gastric tissue from
a different patient, cultured for the same
time, presenting a 46,XY karyotype in all 25
metaphases analyzed.
Discussion
Senescence and cellular morphology of the
ACP01 cell line
Normal cells can divide in vitro only a
limited number of times, and this is called
replicative senescence or senescence. Tu-
mor cells, however, are generally immortal,
and therefore they do not undergo senes-
cence when cultured in vitro (23). Accord-
ing to the “Hayflick limit”, the maximum
number of passages that a normal cell attains
before senescence is about 50; this number
was determined using normal fetal fibro-
blasts (24,25). At this time, line ACP01,
established from a gastric adenocarcinoma
tissue sample, has reached the 63rd passage.
According to previously published reports,
fibroblasts from healthy adults aged 40-50
years go through an average of 30 passages
before reaching senescence (26).
On the basis of these data, it seems evi-
dent that the cells originated from the tumor
tissue sample became immortalized in vitro,
since the patient from whom this material
was obtained was 48 years old when the
Table 1. Distribution of the number of chromosomes per cells in the different cell
generations (passages) of ACP01.
Passage
6th 12th  35th
VCN 37-52 40-100 54-102
Haploid 23-34 (%) 0% 0% 0%
Diploid 35-57 (%) 100% 53.33% 6.06%
Triploid 58-80 (%) 0% 33.33% 87.88%
Tetraploid 81-103 (%) 0% 13.34% 6.06%
Modal number (MN) 44 64 64
No. MN 15 10 15
No. TMA 34 30 33
The data in the table are based on the observation of chromosome number per cells
for each passage. VCN = variation in chromosome number; MN = number of meta-
phases with the modal number of chromosomes; TMA = total number of metaphases
analyzed.
Table 2. Composite karyotypes of the 6th, 12th and 35th generations of cells of cell
line ACP01.
Passages Composite karyotypes Number of cells
6th 34-56, XX, +1(6), +3(6), +7(6), +8(12), 20
-9(4), -12(8), -19(8), -X(3)(cp 20)1
12th 58-95, XXX 20
35th 60-102, XXX 20
1Number of cells with clonal alteration. All cells analyzed presented chromosomal
aberrations.
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surgery was performed. We can therefore
affirm that this cell population had not en-
tered senescence.
The cells presented unorganized growth
in a monolayer, with some agglomerations,
were similar to fibroblasts, and their division
was heterogeneous (bipolar and multipolar),
characteristics which make line ACP01 simi-
lar to other cell lines like the ones from the
primary gastric adenocarcinomas (OACP4
C, MKN7, MKN74, and MKN28) and from
a lymph node metastasis (OACM4.1 C)
(15,27). Walen (28) suggested that these
morphological characteristics might be indi-
cators of the process of in vitro immortaliza-
tion, supporting the conclusion that ACP01
had been immortalized. It should be pointed
out that only 14 of the 59 cell lines that have
been reported are from primary tumors, and
that their morphological characteristics are
similar to those found in our cell line (10,
14,15).
Among the morphological characteris-
tics observed, it is very important to draw
attention to the disorganized growth of this
cell line and to the formation of agglomer-
ates, phenomena that occur due to a loss of
contact inhibition or of density-based growth
control (28,29).
The cellular cycle of this line was about
40 h, with maximum confluence at 74 h. We
reached this conclusion by daily monitoring
the in vitro mitotic activity after each pas-
sage. Comparing the cell cycle of line ACP01
with others described in the literature, we
can conclude that the duration of the cell
cycle in gastric malignancies is heteroge-
neous. For example, line KSGH9201 has a
quite short cell cycle, with cells dividing at
intervals of about 34 h (30), while line KATO-
II has a cell cycle of more than 74 h (10).
All of these data confirm that heteroge-
neous proliferation occurs in cancer, the de-
gree of heterogeneity depending on the stage
of the disease at the time when the tumor is
removed. However, after the point where
ACP01 cells are no longer subject to senes-
cence (after 30 passages), the cycle stabi-
lizes at around 40 h.
Cytogenetic characterization and clonal
evolution of the ACP01 cell line
The cytogenetic analysis of transformed
cell lines at various passages is an excellent
tool for the study of clonal evolution of
malignant diseases (10,15). We analyzed
three different passages (6th, 12th, 35th) of
cell line ACP01. At the 6th passage, the cell
suspension was still in the primary culture
phase; the 12th passage was a long-duration
phase, and, at the 35th passage, the culture
was already an established line. Therefore,
the passages that we examined represent the
different stages of development of a cell line.
No normal karyotype was found in any of
the passages analyzed. This fact strengthens
the hypothesis that, from the 6th passage on,
only neoplastic cells were cultured, with the
normal cells degenerating due to senescence
during the first five passages or during the
cryopreservation procedure.
The cytogenetic data of the 6th passage,
which corresponds to a short-duration cul-
ture, can be compared to published karyo-
type data on primary stomach tumors (4).
Chromosome alterations in this passage had
already been described for this histological
type of tumor, such as trisomies 1, 3, 7, 8,
and 9 (7-9). In our sample, the most frequent
of these alterations was trisomy 8, found in
60% of the cells (Table 1). An important
point is that chromosome 9 monosomy, found
in 20% of the cells of this passage, is among
the most frequently reported (5,9,31). The
proto-oncogene c-myc is located on chromo-
some 8. This gene has recently been consid-
ered to be important in apoptosis induced by
proto-oncogenes in human tumors (32). Pre-
vious reports, together with the information
obtained in the present study, suggest that
chromosome trisomy, associated or not with
other chromosome aberrations, starts in less
advanced stages of the disease, at times even
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before the appearance of metastases (9).
The 12th passage, which is a long-dura-
tion cell culture cycle, was characterized
mainly by the presence of triploid cells; there-
fore we can deduce that clonal evolution of
line ACP01 occurred through polyploidiza-
tion from diploid after the 6th passage to
triploid after the 12th passage.
Atkin (33) suggested that polyploidiza-
tion could be a characteristic of carcinogen-
esis, since the aggressiveness of a cancer is
related to the degree of genomic instability,
associated with chromosome selection.
Therefore, the increase in the population of
polyploid cells could be a genetically un-
stable intermediate stage during the progres-
sion of many types of cancer (28).
We believe that the polyploidization in
line ACP01 arose through cellular endoredu-
plication. This hypothesis is based on the
fact that we observed a large number of
endoreduplicated cells (Figure 3). Non-pro-
grammed proliferation of cells that grow
relatively fast can accumulate various er-
rors. The high mitosis rate can alter the
process of chromosome organization or chro-
mosome connection to the spindle fibers,
causing chromosome alterations such as en-
doreduplication (28,34).
The 35th passage involves cells that have
passed the limit of senescence (26). Cytoge-
netic analysis revealed the maintenance of
triploid cells and a decrease in the number of
diploid cells, which were still present at the
12th passage.
Many of the triploid and/or tetraploid
cells found in the 12th as well as in the 35th
passage did not have 69 or 92 chromosomes
(perfect polyploids), but rather numbers close
to these. To explain this phenomenon, we
should consider the process of polyploidiza-
tion in solid tumors, in which the loss or gain
of chromosomes is random. This model sug-
gests that polyploidization plays a key role in
the evolution of the disease, given its high
degree of aggressiveness (28,35,36). Abar-
banel et al. (8), who performed a cytogenetic
analysis of various gastric tumors, found
triploids and tetraploids in advanced stages
of the disease, with cytogenetic alterations
being more complex in more advanced phases
of the tumor.
We did not detect any clonal marker chro-
mosomes or double minutes, which are com-
monly found in human tumor lines. It seems
likely that, in passages exceeding the 35th,
such aberrations are seen in a clonal form. In
one cell, non-clonal structural alterations
were found involving chromosomes 1, 9,
and 17. It is possible that clonal expansion
can fix such structural alterations in the cell
population in subsequent mitoses or that, on
the other hand, these aberrations do not pro-
vide any adaptive advantage to the cells in
transformation and therefore are eliminated.
We believe that the latter hypothesis is cor-
rect, since the structural alterations were
found only in the 6th passage, but not in the
12th or the 35th.
As the tumor line ACP01 presented aneu-
ploidies, it may be considered a prospect
towards the application of molecular cytoge-
netic techniques, mainly comparative ge-
nomic hybridization, which would allow a
more detailed analysis of chromosome losses
and gains in this cell line.
The characteristics of the ACP01 cell
line described here show that the develop-
ment of stomach cancer is multifactorial and
passes through multiple stages involving pro-
gressive genetic changes and clonal expan-
sion.
Figure 3. Polyploidization by en-
doreduplication in ACP01, a cell
line established from a primary
human gastric tumor.
50 µm
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